Chroma Therapeutics
Chroma Therapeutics is focused on the R&D of novel small molecule drugs based on chromatin biology and cell accumulation.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD151—227m (Dealroom.co estimates Jun 2009.)
Company register number 04066289
Winnersh England (HQ)
Authorizing premium user...